At Kailera, we are bold, authentic and committed to our mission of developing therapies that give people the power to transform their lives and elevate their overall health. Rooted in an entrepreneurial spirit and a team-oriented culture, we are working together to advance Kailera’s mission to advance novel therapies for obesity and related conditions.
We are passionate about creating an inclusive workplace that promotes collaboration, integrity, and excellence. As we expand, we seek the most talented individuals with diverse backgrounds, cultures, perspectives, and experiences to join our team.
What You’ll Do:
The Clinical Trial Manager will provide project support to team members by leading and/or participating in the daily management of clinical trial activities. Successful candidate will be working closely with and will be responsible for oversight of study activities through our CROs and service providers, including study start-up, conduct, and completion.
This position provides an opportunity to join a rapidly growing Clinical Operations organization and contribute substantially to the building of the department and the successful implementation of trials.
Required location: Waltham, MA (hub-based, onsite 3-4 days per week)
Responsibilities:
- Perform as the lead interface with the CRO regarding status of project activities and deliverables (including but not limited to site identification and selection, pre-study activities, enrollment, management/conduct, database lock, post-study activities)
- Collaborate with the cross-functional clinical trial team to review and prepare various clinical study documents including but not limited to study protocol, model informed consent forms, and study plans
- Lead day-to-day management of external vendors, as needed, to support the trial design and implementation
- Review and approve internal and external vendor study plans and processes, as applicable
- Review monitoring reports and interact with CRO to ensure the quality of monitoring and site management
- Work with cross-functional team to ensure data query management and data retrieval is taking place in a timely manner
- Review deviation listings and site audit reports and work with team to resolve site issues (e.g., staff retraining, additional resources)
- Maintain and ensure the quality and completeness of study master files in compliance with GCP
- Lead Clinical Study Team meetings internally, and/or with CRO and service providers
Required Qualifications:
- Work experience to include a minimum of 6 years clinical trial experience with a solid understanding of functional area responsibilities associated with the clinical development process
- Good working knowledge of ICH-GCP guidelines and regulatory requirements for clinical trial management
- Must have strong clinical study management, communication (oral and written), and analytical skills
- Excellent interpersonal skills, with a demonstrated ability to work in a team environment as well as independently
- Additional attributes include an ability to multi-task, be flexible, and to thrive in a fast-paced environment
- Demonstrated ability to effectively manage external vendors & CROs
- Advanced proficiency in Microsoft Office and Microsoft Project or other Project Management software
- Demonstrated strong written and verbal communication skills
- Must be able to travel
Education:
- BA/BS; Life Science degree a plus
For Full Time Roles: This range represents the company’s good-faith estimate of the salary at the time of posting. Actual pay may vary based on experience, skills, qualifications, location, and internal equity. We also offer comprehensive health coverage, flexible time off, paid holidays, and a year-end shutdown. Enjoy a monthly wellness stipend, generous 401(k) match, tuition reimbursement, commuter benefits, disability and life insurance, plus annual bonus opportunities and equity grants—because your well-being and future matter to us.
EQUAL EMPLOYMENT OPPORTUNITY INFORMATION:
Kailera Therapeutics, Inc. is an Equal Opportunity Employer that does not discriminate on the basis of actual or perceived race (including traits historically associated with race, such as hair texture and protective hairstyles), color, creed, religion (including religious dress and grooming practices), national origin, ancestry, citizenship status, age (40 and over), sex or gender (including pregnancy, childbirth, pregnancy-related conditions, and lactation), gender identity or expression (including transgender status), sexual orientation, marital status, military service and veteran status, physical or mental disability, genetic information, reproductive health decisions, domestic victim status, political affiliation, or any other characteristic protected by applicable federal, state, or local laws and ordinances.
E-Verify:
Kailera Therapeutics, Inc. uses E-Verify to confirm the identity and employment eligibility of all new hires.
#LI-Hybrid
Skills Required
- Minimum 6 years of clinical trial experience
- Understanding of functional area responsibilities associated with the clinical development process
- Working knowledge of ICH-GCP guidelines and regulatory requirements for clinical trial management
- Strong clinical study management, oral and written communication, and analytical skills
- Excellent interpersonal skills and ability to work independently and in a team environment
- Ability to multitask, remain flexible, and thrive in a fast-paced environment
- Ability to effectively manage external vendors and CROs
- Advanced proficiency in Microsoft Office and Microsoft Project or other project management software
- Strong written and verbal communication skills
- Ability to travel
- BA or BS degree
- Life Science degree
What We Do
Kailera is an advanced clinical-stage biotechnology company focused on obesity care. It is developing a diversified pipeline of GLP-1 therapies and other obesity-management medications intended to provide treatment options for people living with obesity across their treatment journeys. The company’s team has experience developing and commercializing therapies for metabolic diseases, and its clinical-stage candidates use multiple GLP-1 mechanisms and routes of administration.
